| Current Price | $1.40 | Mkt Cap | $16.3M |
|---|---|---|---|
| Open | $1.42 | P/E Ratio | 0.00 |
| Prev. Close | $1.40 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.36 - $1.45 | Volume | 120,595 |
| 52-Wk Range | $0.84 - $5.50 | Avg. Daily Vol. | 381,984 |
The Company manufactures, sells and distributes hemodialysis concentrates and other ancillary medical products and supplies used in the treatment of patients with End Stage Renal Disease.
| Current Price | $1.40 | Mkt Cap | $16.3M |
|---|---|---|---|
| Open | $1.42 | P/E Ratio | 0.00 |
| Prev. Close | $1.40 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.36 - $1.45 | Volume | 120,595 |
| 52-Wk Range | $0.84 - $5.50 | Avg. Daily Vol. | 381,984 |
The best Bull and Bear pitches based on recency and number of recommendations.
There is not a button for "both" or "either" outperform or underperform. I think it will do one or the other, in that a big move is primed because I think it is tired sitting in the doldrums. Either past controversy is behind it, or the stragglers in… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about RMTI.
Recs
lightrock
(< 20)
Submitted: 9/21/2019 9:42:38 PM :
Start Price:
$3.25
NASDAQ:RMTI Score:
-90.72
There is not a button for "both" or "either" outperform or underperform. I think it will do one or the other, in that a big move is primed because I think it is tired sitting in the doldrums. Either past controversy is behind it, or the stragglers in it will finally give up. There should be a button for this kind of opinion.
Recs
LifeScientist
(28.81)
Submitted: 3/2/2016 7:49:25 PM :
Start Price:
$6.11
NASDAQ:RMTI Score:
-176.45
watch
Recs
jtmeltzer
(< 20)
Submitted: 7/13/2015 9:35:54 PM :
Start Price:
$18.00
NASDAQ:RMTI Score:
-180.90
The company is the #2 provider of hemodialysis solutions in the US. They are currently going to launch the only FDA approved iron therapy to treat kidney failure patients. This may save the hemodialysis providers millions in savings as they will need to buy less Epogen. These providers get paid per hemodialysis session - so anyway to reduce expenditures is their only way to improve margins. This stock is about to breakthrough $18 resistance. Don't wait for a pullback.
Find the members with the highest scoring picks in RMTI.
3004pawel (< 20) Score: +328.21
The Score Leader is the player with the highest score across all their picks in RMTI.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| 3004pawel | < 20 | 1/21/2010 |
|
3W | $7.28 | -81.18% | +247.03% | +328.21 | 0 Comment | |
| shorttest4 | 30.08 | 3/8/2010 |
|
5Y | $6.28 | -78.18% | +246.00% | +324.19 | 0 Comment | |
| jroren | 98.38 | 6/21/2010 |
|
3M | $4.58 | -70.09% | +249.49% | +319.57 | 0 Comment | |
| epsdecreases | 22.30 | 10/31/2012 |
|
5Y | $7.40 | -81.49% | +178.70% | +260.19 | 0 Comment | |
| VeryShiny | < 20 | 3/19/2013 |
|
3M | $3.69 | -62.87% | +156.65% | +219.52 | 0 Comment | |
| kevrose31 | 79.04 | 1/10/2014 |
|
1Y | $10.52 | -86.98% | +114.92% | +201.89 | 0 Comment | |
| donp8 | < 20 | 5/19/2014 |
|
3W | $9.97 | -86.26% | +110.63% | +196.89 | 1 Comment | |
| icebit1 | < 20 | 11/4/2014 |
|
5Y | $9.69 | -85.85% | +96.54% | +182.39 | 0 Comment | |
| JCLscapXperiment | 92.10 | 12/15/2014 |
|
5Y | $8.33 | -83.55% | +95.73% | +179.29 | 1 Comment | |
| rothenbr | 59.68 | 8/22/2016 |
|
3Y | $7.24 | -81.08% | +81.13% | +162.21 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
